Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20488910 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Metformin on top of intensive insulin therapy

Indicates status has not been verified in more than two years